Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosante Pharmaceuticals Inc BPAX

Healthcare Biotechnology


NDAQ:BPAX - Post by User

Biosante Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by vforvalueon Jun 20, 2008 1:06pm
741 Views
Post# 15209773

Excellent and Risky Opportunity

Excellent and Risky OpportunityBPAX is testing out one of its newest bio drug LibiGel, a testosterone gel intended to restore loss of sexual desire in women. BPAX has a ton of cash but the drug is still on trial and might not be approved. Nevertheless, there are some major buy out opportunities! If you are a risky investor and believe this drug will succeed just like BPAX's Elestrin drug did, then this opportunity is right for you!

more on this news is found on this interesting article here:
https://www.stockhouse.com//Columnists/2008/June/16/Biopharma-an-attractive-M-A-target-for-large-drug-
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities